Format

Send to

Choose Destination
See comment in PubMed Commons below
Trials. 2012 Oct 8;13:188. doi: 10.1186/1745-6215-13-188.

Efficacy of moxibustion for pre- or stage I hypertension: study protocol for a pilot randomized controlled trial.

Author information

1
Medical Research Division, Korea Institute of Oriental Medicine, Daejeon, South Korea.

Abstract

BACKGROUND:

Hypertension is a risk factor for cardiovascular disease, and the prevalence of hypertension tends to increase with age. Current treatments for hypertension have adverse side effects and poor adherence. The purpose of this study is to evaluate the effects of moxibustion on blood pressure in individuals with pre- or stage I hypertension.

METHODS/DESIGN:

Forty-five subjects with pre- or stage I hypertension will be randomized into three groups: treatment group A (2 times/week), treatment group B (3 times/week), and the control group (non-treated group). The inclusion criteria will be as follows: (1) aged between 19 and 65 years; (2) prehypertension or stage I hypertension (JNC 7, Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure); (3) the participants are volunteers and written consent obtained.The participants in the treatment group A will undergo indirect moxibustion 2 times per week for 4 weeks, and the participants in the treatment group B will undergo indirect moxibustion 3 times per week for 4 weeks. The participants in the control group (non-treated group) will maintain their current lifestyle, including diet and exercise. The use of antihypertensive medication is not permitted. The primary endpoint will be a change in patient blood pressure. The secondary endpoints will be the body mass index, lipid profile, EuroQol and Heart Rate Variability. The data will be analyzed with the Student's t-test and analysis of variance (ANOVA) (p < 0.05).

DISCUSSION:

The results of this study will help to establish the optimal approach for the care of adults with pre- or stage I hypertension.

TRIAL REGISTRATION:

Clinical Research Information Service KCT0000469.

PMID:
23043965
PMCID:
PMC3561138
DOI:
10.1186/1745-6215-13-188
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Support Center